Paychex Currently Down 11 Consecutive Days, on Track for Record Losing Streak -- Data Talk
Dow Jones2026/09/29 14:49Paychex, Inc. (PAYX) is currently at $98.34, down $0.95 or 0.96%
--Would be lowest close since June 30, 2026, when it closed at $98.33
--On pace for largest percent decrease since Sept. 28, 2026, when it fell 2.04%
--Currently down 11 consecutive days; down 17.02% over this period
--Longest losing streak on record (Based on available data back to Aug. 26, 1983)
--Worst 11 day stretch since the 11 days ending March 25, 2020, when it fell 21.68%
--Down 22.77% month-to-date
--Down 12.33% year-to-date
--Down 38.45% from its all-time closing high of $159.78 on June 6, 2025
--Down 22.42% from 52 weeks ago (Sept. 30, 2025), when it closed at $126.76
--Down 23.52% from its 52-week closing high of $128.59 on Oct. 14, 2025
--Up 14.93% from its 52-week closing low of $85.57 on April 10, 2026
--Traded as low as $98.00; lowest intraday level since June 30, 2026, when it hit $97.79
--Down 1.31% at today's intraday low
All data as of 10:45:48 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 29, 2026 10:49 ET (14:49 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays (BCS.US) bets on a merger between Tesla (TSLA.US) and SpaceX (SPCX.US) in December, but prediction markets give only a 19% probability.
Barclays analyst Levy predicts that Tesla and SpaceX may merge before December to achieve AI integration. However, data from Kalshi and Polymarket indicate that the probability of a short-term merger is very low, with the market favoring such a move after 2027.
Barclays (BCS.US) bearish on Dell (DELL.US): No inflection point in AI spending, memory costs are the main reason
Barclays has downgraded Dell from Overweight to Neutral and lowered the target price. The institution noted that corporate AI spending remains low and revenue growth is driven by memory shortages, which stands in stark contrast to Michael Dell’s optimistic outlook.
Sunway Healthcare Director Khoo Chow Huat Sells 200,000 Shares